A detailed history of Silverarc Capital Management, LLC transactions in Evelo Biosciences, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 61,700 shares of EVLO stock, worth $0. This represents 0.25% of its overall portfolio holdings.

Number of Shares
61,700
Holding current value
$0
% of portfolio
0.25%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.